BrainSonix is a privately held company founded by Dr. Alexander Bystritsky, specializing in developing and manufacturing a medical device platform based on their patented Low Intensity Focused Ultrasound Pulsation (LIFUP) technology. The company aims to modulate brain function non-invasively for various medical applications, including neurological disorders like epilepsy and Parkinson's, psychiatric conditions such as anxiety and mood disorders, chronic pain, obesity, drug development, and functional brain mapping. BrainSonix's innovative approach offers a viable alternative for individuals who do not find relief from standard treatments, focusing on non-invasive and targeted solutions.